Brefeldin a induces p53 -independent apoptosis in primary cultures of human prostatic cancer cells

Journal of Urology

Volumn 164, Issue 3 I, 2000, Pages 836-841

  Wallen, Eric ^a   Sellers, Robert G ^a   Peehl, Donna M ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Brefeldin A; Chemotherapy; P53; Prostate cancer

Indexed keywords

BREFELDIN A; DNA FRAGMENT; PROTEIN P53; TRYPAN BLUE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA;

EID: 0033903708     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)67323-5     Document Type: Article

References (28)

1. Landis, S. H., Murray, T., Bolden, S. and Wingo, P. A.: Cancer statistics, 1999 [see comments]. CA Cancer J Clin, 49: 8, 1999
2. Tang, D. G. and Porter, A. T.: Target to apoptosis: a hopeful weapon for prostate cancer. Prostate, 32: 284, 1997
3. Ko, L. J. and Prives, C.: p53: puzzle and paradigm. Genes Dev, 10: 1054, 1996
4. Girinsky, T., Koumenis, C., Graeber, T. G., Peehl, D. M. and Giaccia, A. J.: Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents. Cancer Res, 55: 3726, 1995
5. Lowe, S. W., Ruley, H. E., Jacks, T. and Housman, D. E.: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957, 1993
6. Hannun, Y. A.: Apoptosis and the dilemma of cancer chemotherapy. Blood, 89: 1845, 1997
7. Navone, N. M., Troncoso, P., Pisters, L. L., Goodrow, T. L., Palmer, J. L., Nichols, W. W., von Eschenbach, A. C. and Conti, C. J.: p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst, 85: 1657, 1993
8. Sausville, E. A., Duncan, K L. K., Senderowicz, A., Plowman, J., Randazzo, P. A., Kahn, R., Malspeis, L. and Grever, M. R.: Antiproliferative effect in vitro and antitumor activity in vivo of brefeldin A. Cancer J Sci Am, 2: 52, 1996
9. Fujiwara, T., Oda, K., Yokota, S., Takatsuki, A. and Ikehara, Y.: Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J Biol Chem, 263: 18545, 1988
10. Pelham, H. R.: Multiple targets for brefeldin A. Cell, 67: 449, 1991
11. Shao, R. G., Shimizu, T. and Pommier, Y.: Brefeldin A is a potent inducer of apoptosis in human cancer cells independently of p53. Exp Cell Res, 227: 190, 1996
12. Guo, H., Tittle, T. V., Allen, H. and Maziarz, R. T.: Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2. Exp Cell Res, 245: 57, 1998
13. Konno, S., Mordente, J. A., Chen, Y., Wu, J. M., Tazaki, H. and Mallouh, C.: Effects of brefeldin A on androgen receptor-mediated cellular responses in human prostatic carcinoma LNCaPcells. Mol Urol, 2: 7, 1998
14. Mordente, J. A., Konno, S., Chen, Y., Wu, J. M., Tazaki, H. and Mallouh, C.: The effects of brefeldin A (BFA) on cell cycle progression involving the modulation of the retinoblastoma protein (pRB) in PC-3 prostate cancer cells. J Urol, 159: 275, 1998
15. Chapman, J. R.: Brefeldin A-induced apoptosis in prostatic cancer DU-145 cells: a possible p53-independent death pathway. Br J Urol Int, 83: 703, 1999
16. Schmid, H. P. and McNeal, J. E.: An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol, 16: 184, 1992
17. Peehl, D. M., in: Culture of Epithelial Cells. Edited by R. I. Freshney. Wiley-Liss, Inc.: New York, p 159, 1992
18. Tsao, M. C., Walthall, B. J. and Ham, R. G.: Clonal growth of normal human epidermal keratinocytes in a defined medium. J Cell Physiol, 110: 219, 1982
19. Park, D. J. and Patek, P. Q.: Detergent and enzyme treatment of apoptotic cells for the observation of DNA fragmentation. Biotechniques, 24: 558, 1998
20. Ishii, S., Nagasawa, M., Kariya, Y. and Yamamoto, H.: Selective cytotoxic activity of brefeldin A against human tumor cell lines. J Antibiot (Tokyo), 42: 1877, 1989
21. Peehl, D. M., Erickson, E., Malspeis, L., Mayo, J., Camalier, R. F., Monks, A., Cronise, P., Paull, K and Grever, M. R., in Fundamental Approaches to the Diagnosis and Treatment of Prostate Cancer and BPH. Edited by K. Imai, J. Shimazaki, and J. P. Karr. Academic Press: New York, p 57, 1994
22. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S. and Boyd, M. R.: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst, 82: 1107, 1990
23. Paull, K. D., Shoemaker, R. H., Hodes, L., Monks, A., Scudiero, D. A., Rubinstein, L., Plowman, J. and Boyd, M. R.: Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J Natl Cancer Inst, 81: 1088, 1989
24. Weinstein, J. N., Myers, T. G., PM, O. C., Friend, S. H., Fornace, A. J., Jr., Kohn, K W., Fojo, T., Bates, S. E., Rubinstein, L. V., Anderson, N. L., Buolamwini, J. K. and van Osdol, W. W.: An information-intensive approach to the molecular pharmacology of cancer. Science, 275: 343, 1997
25. Weller, M.: Predicting response to cancer chemotherapy: the role of p53. Cell Tissue Res, 292: 435, 1998
26. Heidenberg, H. B., Bauer, J. J., McLeod, D. G., Moul, J. W. and Srivastava, S.: The role of the p53 tumor suppressor gene in prostate cancer: a possible biomarker? Urology, 48: 971, 1996
27. Peyroche, A., Antonny, B., Robineau, S., Acker, J., Cherfils, J. and Jackson, C. L.: Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex: involvement of specific residues of the Sec7 domain. Mol Cell, 3: 275, 1999
28. Chardin, P. and McCormick, F.: Brefeldin A: the advantage of being uncompetitive. Cell, 97: 153, 1999